✦ LIBER ✦

Once-weekly alendronic acid more effective than daily risedronic acid in the treatment of postmenopausal osteoporosis

Book ID: 120863464
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 151 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213380-00030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alendronic Acid Produces Greater Effects

Alendronic Acid Produces Greater Effects than Risedronic Acid on Bone Density and Turnover in Postmenopausal Women with Osteoporosis

✍ Dr David M. Reid, David Hosking, David Kendler, Maria L. Brandi, John D. Wark, G 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 153 KB

Therapeutic equivalence of alendronate 3

Therapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosis

✍ Marjorie M Luckey; Nigel Gilchrist; Henry G Bone; Michael W Davie; Tobias J de V 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 198 KB

Cost-effectiveness model of using zoledr

Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis

✍ Patrice Fardellone; Bernard Cortet; Erick Legrand; Xavier Bresse; Ségolène Bisot 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 232 KB

A comparative study of the effects of da

A comparative study of the effects of daily minodronate and weekly alendronate on upper gastrointestinal symptoms, bone resorption, and back pain in postmenopausal osteoporosis patients

✍ Toru Yoshioka, Nobukazu Okimoto, Ken Okamoto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 261 KB

The effect of intravenous zolendronic ac

The effect of intravenous zolendronic acid (ZOL) 5mgs once yearly in the treatment of postmenopausal osteoporosis. A peripheral quantitative computed tomography (PQCT) study

✍ K. Stathopoulos; P. Katsimbri; E. Metania; E. Atsali; E. Eustathopoulos; A.B. Zo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi